Professional Documents
Culture Documents
A. Education
Also remember fat tissue (adipocytes) release: leptins and adiponectins that can
lead to joint damage directly.
For a lower limb OA joint, using a cane in the opposite hand to the
E. Emotional support
A. Oral medications
-1-
ii) NSAIDs (Non Steroidal Anti Inflammatory Drugs)
What are the pros and what are the con's of NSAIDs ?
PRO's of NSAIDs can help inflammation and pain (even in this "non inflammatory"
form of arthritis.
CON's of NSAIDs:
THUS...
Clinical TIP:
The Cox -2 selective NSAIDs (Celexicob ) does not affect the upper GI mucosa...it's
main reason for being developed.
-2-
ALL NSAIDS, both non selective and COX-2 selective can:
Affect renal function , especially if patient has high BP, they can increase BP
Clinical TIP:
In a patient on chronic NSAIDs, esp if older. follow CBC to r/o low hemoglobin
and check creatinine and probably liver enzymes every few months.
Controversy but we need to treat pain. Try tramadol first, but as one of your
fellow students pointed out so well, it is not covered by pharmacare so in a real
world, may reach out to tyl #3 or even something stronger.
Consider for your interest reading Canadian and BC guidelines for Opiates in non
Cancer care.
-3-
C. INJECTABLE TREATMENTS
( and the pros and cons and controversies) (ACR says yes)
Efficacy not clear. Not recommended by ACR but often tried in OA knee
About a toss of a coin if these will work in a given pt. Expensive. If you are facing
total knee replacement, it might be worth trying HA injections
-Medical marijuana Mainly use of CBD oil which does not have s/es of CBD.
-NUTRACEUTICALS
Provide GAG substrate. Inhibit IL-1 and matrix metalloproteases (those nasty
enzymes like MMP-1 and 13 (collagenases) and MMP 3 (stromelysin:
proteoglycanase)
-4-
THERAPEUTIC HORIZONS IN OA:
Just be aware of the terms --WOMAC and AIMS2 (SF (Shortened form) are tools
we use in Rheumatology in assessing outcome for OA. Do not worry about
anything more on these... just want you to realize we must be rigorous in
measuring outcomes to therapy.
-5-